β-galactosidase transduced T lymphocytes: A comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction

Haematologica

Volumn 81, Issue 5, 1996, Pages 410-417

  Di Ianni, Mauro ^a   Casciari, Carla ^a   Ciurnelli, Raffaella ^a   Fulvi, Antonella ^a   Bagnis, Claude ^b   Lucheroni, Francesco ^a   Falzetti, Franca ^a   Mannoni, Patrice ^b   Martelli, Massimo F ^a   Tabilio, Antonio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

LacZ; Retroviral vectors; T lymphocytes

Indexed keywords

BETA GALACTOSIDASE; INTERLEUKIN 2; MITOMYCIN C; PHYTOHEMAGGLUTININ; VIRUS VECTOR;

ALLOIMMUNITY; ARTICLE; COMPARATIVE STUDY; CYTOTOXIC T LYMPHOCYTE; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MIXED LYMPHOCYTE REACTION; RETROVIRUS; T LYMPHOCYTE ACTIVATION; TARGET CELL;

BETA-GALACTOSIDASE; DRUG RESISTANCE, MICROBIAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; PHYTOHEMAGGLUTININS; RETROVIRIDAE; T-LYMPHOCYTES;

EID: 0030322226     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Brenner MK, McGarrity GJ, Kohn DB, Heslop HE. The practise of clinical gene therapy. Education Program of The American Society of Hematology. Seattle: American Society of Hematology, 1995:93-100.
2. Culver K, Cornetta K, Morgan R, et al. Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci USA 1991; 88:3155-9.
3. Mulligan RC. The basic science of gene therapy. Science 1993; 250:926-32.
4. Anderson WF. Human gene therapy. Science 1992; 256:808-13.
5. Djian P, Philips M, Green H. Suppression of SV40-promoted gene expression by differentiation of preadipose cells. Genes Dev 1988; 2:1251-7.
6. MacGregor GR, Mogg AE, Burke IF, Caskey CT. Histochemical staining of clonal mammalian cell lines expressing E. coli β-galactosidase indicates heterogeneous expression of the bacterial gene. Somat Cell Mol Genet 1987; 13:253-65.
7. Nolan GP, Fiering S, Nicolas JF, Herzenberg LA. Fluorescence-activated cell analysis sorting of viable mammalian cells based on β-D-galactosidase activity after transduction of E. coli LacZ. Proc Natl Acad Sci USA 1988; 85:2603-7.
8. Lojda Z. Indigogenic methods for glycosidases: an improved method for β-galactosidase and its application to localization studies of the enzymes in the intestine and in other tissues. Histochemie 1970; 23:266-88.
9. Murnane RD, Wright RW, Hoffman KR, Prieur DJ. Expression of β-galactosidase in preimplantation ovine and porcine embryos. Proc Soc Exp Biol Med 1990; 194:144-8.
10. Kalderon D, Roberts BL, Richardson WD, Smith AE. A short amino acid sequence able to specify nuclear localization. Cell 1984; 39:499-509.
11. Huang C, Samsonoff WA, Grzelecki A. Vaccinia virus recombinants expressing an 11-kilodalton β-galactosidase fusion protein incorporate active β-galactosidase in virus particles. J Virol 1988; 62:3855-61.
12. Turner DL, Cepko CL. A common progenitor for neurons and glia persists in rat retina late in development. Nature 1987; 328:131-6.
13. Friedrich G, Soriano P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Gene Dev 1991; 5:1513-23.
14. Baron M, Reynes JP, Stassi D, Tiraby G. A selectable bifunctional β-galactosidase: phleomycin resistance fusion protein as a potential marker for eukaryotic cells. Gene 1992; 114:239-43.
15. Imbert AM, Costello R, Imbert J, Mannoni P, Bagnis C. Highly efficient retroviral gene transfer into human primary T-lymphocytes derived from peripheral blood. Cancer Gene Ther 1994; 1:259-65.
16. Friedich G, Soriano P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Gene Dev 1991; 5:1513-23.
17. Lynch CM, Miller AD. Production of high-titer helper virus-free retroviral vectors by cocultivation of packaging cells with different host ranges. J Virol 1991; 65:3887-90.
18. Bagnis C, Chabannon C, Mannoni P. Marking human progenitors and T lymphocytes with β-galactosidase genes. Cancer Gene Ther 1996; in press.
19. Bach F, Hirschhorn K. Lymphocyte interaction: a potential histocompatibility test in vitro. Science 1964; 143:813.
20. Markowitz DS, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62:1120-4.
21. Markowitz DS, Goff S, Bank A. Construction and use of a safe and efficient packaging cell line. Virology 1988; 85:400-6.
22. rd ed. New York: Wiley-Liss, 1995.
23. Varmus H. Retroviruses. Science 1988; 240:1427-35.
24. Culver KW, Anderson WF, Blaese RM. Lymphocyte in gene therapy. Hum Gene Ther 1991; 2:107-9.
25. Kasid A, Morecki S, Aebersold P, et al. Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man. Proc Natl Acad Sci USA 1990; 87:473-7.
26. Mavilio F, Ferrari G, Rossini S, et al. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 1994; 83:1988-97.
27. Finer MH, Dull DJ, Qin L, Farson D, Roberts MR. Kat: a high efficiency retroviral transduction system for human T lymphocytes. Blood 1994; 83:43-50.
28. Hendrikx PJ, Martens ACM, Schultz FW, Visser JWM, Hagenbeek A. Monitoring of leukemia growth in a rat model using a highly sensitive assay for the detection of LacZ marked leukemic cells. Leukemia 1995; 9:1954-60.